Screening Milestone definition

Screening Milestone means the Initial Screening Phase activities, expected progress, and timeline milestones for a particular Initial Screening Phase initiative, Product, Derivative, and/or Field, as specified in Exhibit B.
Sample 1
Screening Milestone has the meaning set forth in Section 5.4.3. 1.103 “Screening [***] Option” has the meaning set forth in Section 4.3.
Sample 1

Examples of Screening Milestone in a sentence

  • If Stepan fails to meet any such Screening Milestone, Stepan shall provide prompt notice to ERS of such failure.

  • At each Baggage Screening Milestone Date, and upon mutual agreement of the parties as to continued development of the QSTM Baggage Screening Prototype, Rapiscan shall pay IMX an additional Two Hundred Twenty Five Thousand Dollars ($225,000).

  • Notwithstanding the foregoing, a Screening Milestone shall be equitably adjusted to the extent Stepan is not able to meet such [***] Indicates that text has been omitted which is the subject of a confidential treatment request.

  • The Baggage Screening Statement of Work shall set forth the specifications, nature and timing of the work necessary to develop the QSTM Baggage Screening Prototype and three (3) key milestone dates to be used for purposes of evaluating the continued feasibility of development (the “Baggage Screening Milestone Dates”).

  • Screening Milestone or such Screening Milestone is not otherwise met as a result of the failure of ERS to meet any agreed-upon obligation it has in connection with the Initial Screening Phase, with an appropriate extension to such Screening Milestone commensurate with the delay caused by such ERS failure.

  • Such notice shall specify the Product, Developed ERS Products and/or Derivative and the Field or portion of the Field affected by the failure to meet any such Screening Milestone.

Related to Screening Milestone

  • Milestone 2 means achievement of annual Net Sales of at least $35,000,000 during any Calendar Year ending on or before December 31, 2024.

  • Milestone Date means the date set against the relevant Milestone in the Implementation Plan;

  • Milestone Event has the meaning set forth in Section 8.4.

  • Development Milestone Event has the meaning set forth in Section 7.1.

  • Milestone 1 means achievement of annual Net Sales of at least $20,000,000 during the Calendar Year ending on December 31, 2021.

  • Milestone means an event or task described in the Implementation Plan which, if applicable, must be completed by the relevant Milestone Date;

  • Development Milestone Payment shall have the meaning set forth in Section 9.2(a).

  • Milestone Events has the meaning set forth in Section 3.3 (Milestone Payments).

  • Performance Milestone means an act or event specified in section 5.1 and described in section 9 of the EPLA.

  • Milestone Dates means the dates for completion of specified Project activities as contained in the Project Schedule.

  • Sales Milestone Payment is defined in Section 5.3.

  • Project Milestone means the project milestone set forth in Schedule-J;

  • Project Milestones means the project milestones set forth in Schedule-G;

  • Milestones means control points in the project that help to chart progress. Milestones may correspond to the completion of a key deliverable, allowing the next phase of the work to begin. They may also be needed at intermediary points so that, if problems have arisen, corrective measures can be taken. A milestone may be a critical decision point in the project where, for example, the consortium must decide which of several technologies to adopt for further development.

  • Milestone Failure means a failure by the Grant Recipient fully to achieve any Milestone by the relevant Milestone Date;

  • KPI Target means the acceptable performance level for a KPI as set out in each KPI;

  • Milestone Payment means a payment identified in the Implementation Plan to be made following the issue of a Satisfaction Certificate in respect of Achievement of the relevant Milestone;

  • Milestone Payment Date has the meaning set forth in Section 2.4(a).

  • Soft Target means a target that will suffer minimum damage and cause minimum damage to the subject vehicle in the event of a collision.

  • Milestone Schedule means Seller’s milestone schedule, the form of which is attached to this Agreement as Exhibit Q.

  • Second Target Distribution means $0.4375 per Unit per Quarter (or, with respect to the period commencing on the Closing Date and ending on September 30, 2005, it means the product of $0.4375 multiplied by a fraction of which the numerator is equal to the number of days in such period and of which the denominator is 92), subject to adjustment in accordance with Section 6.6 and Section 6.9.

  • Third Target Distribution means $0.5250 per Unit per Quarter (or, with respect to the period commencing on the Closing Date and ending on September 30, 2005, it means the product of $0.5250 multiplied by a fraction of which the numerator is equal to the number of days in such period and of which the denominator is 92), subject to adjustment in accordance with Section 6.6 and Section 6.9.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Quarterly (1/Quarter) sampling frequency means the sampling shall be done in the months of March, June, August, and December, unless specifically identified otherwise in the Effluent Limitations and Monitoring Requirements table.

  • EBITDA Target means the Company's projected earnings before interest, taxes, one-time transition expenses, non-cash compensation expense charges, depreciation and amortization, as contained in the Company's budget for the Applicable Period and which is approved by the Board (without reference to any adjustments or revision, upwards or downwards, to such projected earnings which are subsequently approved by the Board as part of any subsequent revision to such budget), and (ii) the term "Financial Results" shall mean the Company's EBITDA calculated by reference to the Company's financial statements for the Applicable Period as filed with the Securities and Exchange Commission (the "SEC").

  • Phase III Clinical Study means a human clinical study of a product on a sufficient number of subjects that is designed to establish that such product is safe and efficacious for its intended use, and to determine warnings, precautions, and adverse reactions that are associated with such product in the dosage range to be prescribed, which trial is intended to support Regulatory Approval of such product, as described in 21 C.F.R. 312.21(c). 1.185. [***] 1.186. [***]